<DOC>
	<DOCNO>NCT01889160</DOCNO>
	<brief_summary>Study investigate safety profile AZD4721 single dos different dose level</brief_summary>
	<brief_title>Study Investigate Safety Profile AZD4721 After Single Doses Different Dose Levels</brief_title>
	<detailed_description>A study investigate safety tolerability single ascending dos AZD4721 give healthy volunteer . Including bioequivalence part compare solution AZD4721 suspension .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . Healthy male and/or female Caucasian ( neither Black/African American Japanese ) volunteer age 1850 year . ( `` Healthy '' determine medical history physical examination , clinical laboratory parameter , ECG ) 2 . Females must negative pregnancy test screen admission unit , must lactate must nonchildbearing potential 3 . Volunteers BMI 18 30 kg/m2 ( inclusive ) weigh least 50 kg 100 kg ( inclusive ) . 1 . History clinically important disease disorder , opinion Investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate 2 . Current smoker smoke used nicotine product within previous 3 month 2.Clinically significant low respiratory tract infection resolve within 4 week prior Visit 1 , determine Investigator 4 . Other latent chronic infection ( eg , recurrent sinusitis , genital ocular herpes , urinary tract infection ) risk infection ( surgery , trauma , significant infection ) previous 90 day , history skin abscess within previous</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Healthy volunteer , Phase 1</keyword>
</DOC>